News & Trends - Medical Technology

BD marks landmark delivery of vaccine devices

Health Industry Hub | November 18, 2020 |
[Total: 1    Average: 5/5]

MedTech News: Today marks BD’s (Becton, Dickinson and Company) first milestone delivery of vaccine devices to the Australian Commonwealth Department of Health (DoH), commencing the partnership with the Federal Government in supplying a COVID-19 vaccine to every Australian, once available.

This landmark delivery of MedTech consumables is the only agreement the Government has announced to date. 

Through this partnership, BD will deliver millions of disposable needles, syringes and sharps collectors over the next 12 months, to support Australia’s COVID-19 Vaccine and Treatment Strategy. The partnership will also ensure sufficient in-country supply, should more injection devices for vaccine delivery be required.

Representing the world’s largest manufacturer of injection devices, Managing Director and Vice President of BD Australia and New Zealand (BD ANZ), Ms Anelo Cournut, applauded the Government today for its proactive approach in planning for future pandemics.

“Today’s first delivery of BD products marks an important milestone for our company. We are proud to be part of an innovative collaboration between Government, manufacturers, researchers, and clinicians, alike.

“Our collective goal is to guarantee that when the time arrives, every Australian can access a COVID-19 vaccine.

“BD is committed to ensuring product continuity through our robust and agile supply chain, with local manufacturing partners in Australia, and around the globe,” said Ms Cournut.

“BD will work in close collaboration with the Government over the next 12 months, to ensure the supply of vital vaccine delivery devices, to enable every Australian to access a COVID-19 vaccine, once available.”

In addition to delivering vaccine products, BD is also liaising with the Department of Health, including the Therapeutic Goods Administration and State healthcare systems to expand the nation’s access to diagnostic testing and treatment support for COVID-19 patients. This includes swabs for influenza and COVID-19 testing, rapid molecular diagnostic tests utilising the BD MAX™ System, and 15-minute point-of-care antigen testing with the BD Veritor™ Plus System.

In addition, BD supplies infusion pumps, which are essential for use in the ICU, infusion sets, cannulas, central line catheters and targeted temperature management systems to support intensive care unit patients. Researchers are also using BD Biosciences instrumentation for cellular analysis worldwide, and locally, to better understand the immune response to COVID 19.

According to CEO of the Medical Technology Association of Australia (MTAA), Mr Ian Burgess, Australia’s medical technology (MedTech) industry has been recognised for its response to the challenges of COVID-19 to date, particularly for ensuring the ongoing supply of essential medical supplies.

“The ‘Australian Model’ of industry collaboration with Government throughout COVID-19 is the globally recognised benchmark. MTAA, along with industry partners, has been working with Government, including The Hon. Karen Andrews MP, Minister for Industry, and The Hon. Greg Hunt MP, Minister for Health, to ensure all Australians have continued access to life-saving and life-changing medical devices.

“During COVID-19 the Government asked MedTech to supply 7,500 ventilators, and over 10 million COVID-19 test kits; the MedTech supply chain worked, and the ventilators and other essential medical equipment were delivered. Now Government has asked for vaccine devices and again MedTech delivered,” Mr Burgess said.

With more than 65 years of strong history in vaccine delivery, BD has partnered with governments worldwide to produce and supply billions of vaccine delivery devices. Importantly, due to the company’s strong manufacturing capacity and well-established global supply chain, BD will still be able to prioritise existing customer requirements for needles and syringes, including for influenza vaccination programs.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Pharmaceuticals

Pharma News - Novel gene therapy in advanced bowel cancer

Novel gene therapy in advanced bowel cancer

Health Industry Hub | November 27, 2020 |

Pharma News: For the first time, SAHMRI and University of Adelaide researchers are investigating gene therapy as an option to […]

More


Best Practice

Best Practice Pharma Biotech Medtech -Search for meaning more fulfilling than the pursuit of personal happiness

Search for meaning more fulfilling than the pursuit of personal happiness

Health Industry Hub | November 27, 2020 |

There is a myth in our culture that the search for meaning is some esoteric pursuit – that you have […]

More


Medical

Medical Pharma Biotech MedTech - Professor Kay Crossley wins top science award

Professor Kay Crossley wins top science award

Health Industry Hub | November 26, 2020 |

Medical News: World-renowned physiotherapist and La Trobe University Professor, Kay Crossley, has been awarded Victoria’s highest scientific honour, today receiving […]

More


News & Trends - Medical Technology

MedTech News - Growth of the surgical robotics market in Australia

Growth of the surgical robotics market in Australia

Health Industry Hub | November 25, 2020 |

In Australia, the penetration of surgical robots has been limited to a range of products that are manufactured internationally. Australia […]

More